Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Comparative Modeling and Molecular Dynamics Simulation of Substrate Binding in Human Fatty Acid Synthase: Enoyl Reductase and β-Ketoacyl Reductase Catalytic Domains

  • John, Arun (Centre for Bioinformatics, Vision Research Foundation, Sankara Nethralaya) ;
  • Umashankar, Vetrivel (Centre for Bioinformatics, Vision Research Foundation, Sankara Nethralaya) ;
  • Krishnakumar, Subramanian (Larsen and Toubro Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya) ;
  • Deepa, Perinkulam Ravi (Department of Biological Sciences, Birla Institute of Technology and Science)
  • Received : 2014.11.25
  • Accepted : 2015.02.04
  • Published : 2015.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Fatty acid synthase (FASN, EC 2.3.1.85), is a multi-enzyme dimer complex that plays a critical role in lipogenesis. This lipogenic enzyme has gained importance beyond its physiological role due to its implications in several clinical conditions-cancers, obesity, and diabetes. This has made FASN an attractive pharmacological target. Here, we have attempted to predict the theoretical models for the human enoyl reductase (ER) and ${\beta}$-ketoacyl reductase (KR) domains based on the porcine FASN crystal structure, which was the structurally closest template available at the time of this study. Comparative modeling methods were used for studying the structure-function relationships. Different validation studies revealed the predicted structures to be highly plausible. The respective substrates of ER and KR domains-namely, trans-butenoyl and ${\beta}$-ketobutyryl-were computationally docked into active sites using Glide in order to understand the probable binding mode. The molecular dynamics simulations of the apo and holo states of ER and KR showed stable backbone root mean square deviation trajectories with minimal deviation. Ramachandran plot analysis showed 96.0% of residues in the most favorable region for ER and 90.3% for the KR domain, respectively. Thus, the predicted models yielded significant insights into the substrate binding modes of the ER and KR catalytic domains and will aid in identifying novel chemical inhibitors of human FASN that target these domains.

Keywords

References

  1. Wakil SJ. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 1989;28:4523-4530. https://doi.org/10.1021/bi00437a001
  2. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7: 763-777. https://doi.org/10.1038/nrc2222
  3. Smith S, Witkowski A, Joshi AK. Structural and functional organization of the animal fatty acid synthase. Prog Lipid Res 2003;42:289-317. https://doi.org/10.1016/S0163-7827(02)00067-X
  4. Schweizer E, Hofmann J. Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems. Microbiol Mol Biol Rev 2004;68:501-517. https://doi.org/10.1128/MMBR.68.3.501-517.2004
  5. White SW, Zheng J, Zhang YM, Rock CO. The structural biology of type II fatty acid biosynthesis. Annu Rev Biochem 2005;74:791-831. https://doi.org/10.1146/annurev.biochem.74.082803.133524
  6. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 1996;27:917-921. https://doi.org/10.1016/S0046-8177(96)90218-X
  7. Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997;28:686-692. https://doi.org/10.1016/S0046-8177(97)90177-5
  8. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-208.
  9. Vandhana S, Deepa PR, Jayanthi U, Biswas J, Krishnakumar S. Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study. Exp Mol Pathol 2011;90:29-37. https://doi.org/10.1016/j.yexmp.2010.11.007
  10. Liu B, Wang Y, Fillgrove KL, Anderson VE. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol 2002;49:187-193. https://doi.org/10.1007/s00280-001-0399-x
  11. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A 2000;97:3450-3454. https://doi.org/10.1073/pnas.97.7.3450
  12. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011;60: 2441-2449. https://doi.org/10.2337/db11-0425
  13. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet- induced obesity. J Clin Invest 2005;115:1298-1305. https://doi.org/10.1172/JCI200523057
  14. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18. https://doi.org/10.2337/diabetes.51.1.7
  15. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 1998;95:2498-2502. https://doi.org/10.1073/pnas.95.5.2498
  16. Maier T, Leibundgut M, Ban N. The crystal structure of a mammalian fatty acid synthase. Science 2008;321:1315-1322. https://doi.org/10.1126/science.1161269
  17. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics 2006; Chapter 5:Unit 5.6.
  18. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000;29:291-325. https://doi.org/10.1146/annurev.biophys.29.1.291
  19. Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 1993;2: 1511-1519. https://doi.org/10.1002/pro.5560020916
  20. Xu D, Zhang Y. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 2011;101:2525-2534. https://doi.org/10.1016/j.bpj.2011.10.024
  21. Hekkelman ML, Te Beek TA, Pettifer SR, Thorne D, Attwood TK, Vriend G. WIWS: a protein structure bioinformatics Web service collection. Nucleic Acids Res 2010;38:W719-W723. https://doi.org/10.1093/nar/gkq453
  22. Wallner B, Elofsson A. Can correct protein models be identified? Protein Sci 2003;12:1073-1086. https://doi.org/10.1110/ps.0236803
  23. Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepesis JL, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), 2006 Nov 11-17, Tampa, FL, USA. New York: Association for Computing Machinery, 2006. p.43.
  24. Evans DJ, Holian BL. The Nose-Hoover thermostat. J Chem Phys 1985;83:4069. https://doi.org/10.1063/1.449071
  25. Martyna GJ. Remarks on "Constant-temperature molecular dynamics with momentum conservation". Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1994;50:3234-3236.
  26. Darden T, Perera L, Li L, Pedersen L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 1999;7:R55-R60. https://doi.org/10.1016/S0969-2126(99)80033-1
  27. Deepa PR, Vandhana S, Muthukumaran S, Umashankar V, Jayanthi U, Krishnakumar S. Chemical inhibition of fatty acid synthase: molecular docking analysis and biochemical validation in ocular cancer cells. J Ocul Biol Dis Infor 2010;3: 117-128. https://doi.org/10.1007/s12177-011-9065-7
  28. Sippel KH, Vyas NK, Zhang W, Sankaran B, Quiocho FA. Crystal structure of the human fatty acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition. J Biol Chem 2014;289:33287-33295. https://doi.org/10.1074/jbc.M114.608547
  29. Hardwicke MA, Rendina AR, Williams SP, Moore ML, Wang L, Krueger JA, et al. A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site. Nat Chem Biol 2014;10:774-779. https://doi.org/10.1038/nchembio.1603
  30. Yang AS, Honig B. An integrated approach to the analysis and modeling of protein sequences and structures. I. Protein structural alignment and a quantitative measure for protein structural distance. J Mol Biol 2000;301:665-678. https://doi.org/10.1006/jmbi.2000.3973
  31. Kumar S, Dorsey JA, Muesing RA, Porter JW. Comparative studies of the pigeon liver fatty acid synthetase complex and its subunits. Kinetics of partial reactions and the number of binding sites for acetyl and malonyl groups. J Biol Chem 1970;245:4732-4744.

Cited by

  1. Structure Prediction of Human Fatty Acid Synthase–Dehydratase: A Plausible Model for Understanding Active Site Interactions vol.10, pp.1177-9322, 2016, https://doi.org/10.4137/BBI.S38317
  2. Involvement of fatty acid synthase in dengue virus infection vol.14, pp.1, 2017, https://doi.org/10.1186/s12985-017-0685-9